MKA
LH icon

M. Kulyk & Associates’s Labcorp LH Stock Holding History

M. Kulyk & Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.2M Buy
23,255
+694
+3% +$188K 1.16% 29
2025
Q4 		$5.66M Buy
22,561
+1,278
+6% +$339K 1.08% 36
2025
Q3 		$6.11M Buy
21,283
+1,297
+6% +$347K 1.24% 30
2025
Q2 		$5.25M Buy
19,986
+309
+2% +$75.2K 1.14% 32
2025
Q1 		$4.58M Sell
19,677
-2,637
-12% -$640K 1.05% 36
2024
Q4 		$5.12M Sell
22,314
-921
-4% -$211K 1.11% 32
2024
Q3 		$5.19M Buy
23,235
+76
+0.3% +$16.7K 1.04% 37
2024
Q2 		$4.71M Buy
23,159
+2,864
+14% +$583K 1.09% 36
2024
Q1 		$4.43M Buy
20,295
+1,533
+8% +$338K 1.03% 39
2023
Q4 		$4.26M Buy
18,762
+1,040
+6% +$218K 0.99% 38
2023
Q3 		$3.56M Buy
17,722
+1,270
+8% +$268K 0.99% 37
2023
Q2 		$3.41M Buy
16,452
+2,421
+17% +$470K 0.95% 39
2023
Q1 		$2.77M Buy
14,031
+1,109
+9% +$228K 0.84% 41
2022
Q4 		$2.61M Buy
12,922
+592
+5% +$116K 0.87% 42
2022
Q3 		$2.17M Buy
+12,330
New +$2.52M 0.75% 44

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

M. Kulyk & Associates's LH Position: Q1 2026 in Review

M. Kulyk & Associates increased its Labcorp (LH) stake by 3.1% in Q1 2026, buying an estimated $188K and bringing the position to 23,255 shares worth $6.2M. The position accounts for 1.16% of the portfolio, ranked #29.

M. Kulyk & Associates first reported a position in LH in Q3 2022 and has held it in 15 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • M. Kulyk & Associates held 23,255 shares of Labcorp worth $6.2M as of Q1 2026.
  • M. Kulyk & Associates bought 694 Labcorp shares in Q1 2026, an estimated $188K.
  • Labcorp made up 1.16% of M. Kulyk & Associates's portfolio in Q1 2026, its #29 holding.
  • M. Kulyk & Associates first reported a position in Labcorp in Q3 2022 and has held it in 15 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on M. Kulyk & Associates's 13F filing for Q1 2026, filed 6 May 2026.